{"id":134221,"date":"2026-07-07T18:21:35","date_gmt":"2026-07-07T12:51:35","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=134221"},"modified":"2026-07-07T18:21:37","modified_gmt":"2026-07-07T12:51:37","slug":"sai-life-sciences-latest-news-52-week-high","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/","title":{"rendered":"Sai Life Sciences Latest News: Sai Life Sciences Scales 52-Week High of Rs 1,252 Backed by Strong Fundamentals"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Sai Life Sciences latest news: NSE: SAILIFE Rs 1,252 (latest). 52W high Rs 1,252. 52W low Rs 744.10. MCap Rs ~26,500 Cr. P\/E 74.31x. Gain from 52W low: +~68%.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/sailife\/sai-life-sciences-limited-share-price-today\">Sai Life Sciences<\/a> Latest News is in focus as Sai Life Sciences Ltd (NSE: SAILIFE) hit a 52-week high of Rs 1,252, extending a strong rally that has returned ~68% from its 52-week low of Rs 744.10. The CRDMO and Pharmaceutical Services company is backed by strong fundamentals and key business developments driving the Sai Life Sciences latest news story.<\/p>\n<p>This Sai Life Sciences latest news analysis covers the key catalysts behind the rally, what market analysts are observing, the next price targets and key levels to watch, and the risks investors should monitor.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=sai-life-sciences-latest-news-52-week-hi\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#About_Sai_Life_Sciences_Company_Overview\" title=\"About Sai Life Sciences: Company Overview\">About Sai Life Sciences: Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#Sai_Life_Sciences_Latest_News_What_Is_Driving_the_Rally_Key_Reasons\" title=\"Sai Life Sciences Latest News: What Is Driving the Rally? Key Reasons\">Sai Life Sciences Latest News: What Is Driving the Rally? Key Reasons<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#FY26_PAT_Nearly_Doubled_Rs_341_Crore_vs_Rs_173_Crore_in_FY25_97_YoY\" title=\"FY26 PAT Nearly Doubled: Rs 341 Crore vs Rs 173 Crore in FY25 (+97% YoY)\">FY26 PAT Nearly Doubled: Rs 341 Crore vs Rs 173 Crore in FY25 (+97% YoY)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#Jefferies_Buy_Rating_With_Rs_1300_Target_Supports_Premium_Valuation\" title=\"Jefferies Buy Rating With Rs 1,300 Target Supports Premium Valuation\">Jefferies Buy Rating With Rs 1,300 Target Supports Premium Valuation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#Indias_CRDMO_Sector_Growth_and_Sai_Life_Sciences_Integrated_Platform\" title=\"India&#8217;s CRDMO Sector Growth and Sai Life Sciences&#8217; Integrated Platform\">India&#8217;s CRDMO Sector Growth and Sai Life Sciences&#8217; Integrated Platform<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#What_Market_Analysts_Are_Saying_About_Sai_Life_Sciences_Latest_News\" title=\"What Market Analysts Are Saying About Sai Life Sciences Latest News\">What Market Analysts Are Saying About Sai Life Sciences Latest News<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#Sai_Life_Sciences_Latest_News_Next_Price_Targets_and_Key_Levels\" title=\"Sai Life Sciences Latest News: Next Price Targets and Key Levels\">Sai Life Sciences Latest News: Next Price Targets and Key Levels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#Key_Risks_to_Monitor\" title=\"Key Risks to Monitor\">Key Risks to Monitor<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#IGST_Demand_of_Rs_1629_Crore_Pending_Legal_and_Financial_Risk\" title=\"IGST Demand of Rs 162.9 Crore Pending: Legal and Financial Risk\">IGST Demand of Rs 162.9 Crore Pending: Legal and Financial Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#High_PE_of_7431x_Requires_Sustained_PAT_Growth\" title=\"High P\/E of 74.31x Requires Sustained PAT Growth\">High P\/E of 74.31x Requires Sustained PAT Growth<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#China1_CRDMO_Competition_from_Divis_Suven_and_Global_CDMOs\" title=\"China+1 CRDMO Competition from Divi&#8217;s, Suven, and Global CDMOs\">China+1 CRDMO Competition from Divi&#8217;s, Suven, and Global CDMOs<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#Frequently_Asked_Questions_on_Sai_Life_Sciences_Latest_News\" title=\"Frequently Asked Questions on Sai Life Sciences Latest News\">Frequently Asked Questions on Sai Life Sciences Latest News<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#What_is_Sai_Life_Sciences_latest_news_today\" title=\"What is Sai Life Sciences latest news today?\">What is Sai Life Sciences latest news today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#Why_is_Sai_Life_Sciences_at_52-week_high\" title=\"Why is Sai Life Sciences at 52-week high?\">Why is Sai Life Sciences at 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#What_is_Sai_Life_Sciences_business_model\" title=\"What is Sai Life Sciences&#8217; business model?\">What is Sai Life Sciences&#8217; business model?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#What_is_the_Jefferies_target_for_Sai_Life_Sciences\" title=\"What is the Jefferies target for Sai Life Sciences?\">What is the Jefferies target for Sai Life Sciences?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#What_is_Sai_Life_Sciencess_market_cap_and_valuation_at_current_levels\" title=\"What is Sai Life Sciences&#8217;s market cap and valuation at current levels?\">What is Sai Life Sciences&#8217;s market cap and valuation at current levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/sai-life-sciences-latest-news-52-week-high\/#Is_Sai_Life_Sciences_a_buy_at_current_levels\" title=\"Is Sai Life Sciences a buy at current levels?\">Is Sai Life Sciences a buy at current levels?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Sai_Life_Sciences_Company_Overview\"><\/span><strong>About Sai Life Sciences: Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A leading Indian CRDMO (Contract Research, Development, and Manufacturing Organization) incorporated in 1999 and headquartered in Hyderabad. Sai Life Sciences provides integrated drug discovery, development, and commercial manufacturing services to global pharmaceutical innovators. Services span medicinal chemistry, biology, DMPK, CMC chemistry, process development, analytical development, and commercial manufacturing. The company is a recent IPO (listed in late 2024) and serves top global pharma and biotech companies.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px; margin: 12px 0;\">\n<tbody>\n<tr style=\"background: #1F3864; color: #ffffff;\">\n<th style=\"padding: 8px; text-align: left;\">Metric<\/th>\n<th style=\"padding: 8px; text-align: left;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">CMP (Latest)<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Rs 1,252<\/td>\n<\/tr>\n<tr style=\"background: #F5F7FA;\">\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">52-Week High<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Rs 1,252<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">52-Week Low<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Rs 744.10<\/td>\n<\/tr>\n<tr style=\"background: #F5F7FA;\">\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Market Cap<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Rs ~26,500 Cr<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">P\/E Ratio (TTM)<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">74.31x<\/td>\n<\/tr>\n<tr style=\"background: #F5F7FA;\">\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Sector<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">CRDMO and Pharmaceutical Services<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Return from 52W Low<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">+~68%<\/td>\n<\/tr>\n<tr style=\"background: #F5F7FA;\">\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">NSE Symbol<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">NSE: SAILIFE<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Sai_Life_Sciences_Latest_News_What_Is_Driving_the_Rally_Key_Reasons\"><\/span><strong>Sai Life Sciences Latest News: What Is Driving the Rally? Key Reasons<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Three key developments are driving the Sai Life Sciences latest news story to near or at 52-week high levels.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY26_PAT_Nearly_Doubled_Rs_341_Crore_vs_Rs_173_Crore_in_FY25_97_YoY\"><\/span><strong>FY26 PAT Nearly Doubled: Rs 341 Crore vs Rs 173 Crore in FY25 (+97% YoY)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sai Life Sciences delivered exceptional FY26 results: revenue grew 31% to Rs 2,153 crore from Rs 1,642 crore in FY25, and net profit grew 97% to Rs 341.5 crore from Rs 173.5 crore in FY25. This near-doubling of PAT in a single year is driven by operating leverage as the company scales its CRDMO services across the drug discovery, development, and commercial manufacturing continuum. The Sai Life Sciences latest news of a 52-week high reflects the market&#8217;s recognition of the exceptional FY26 earnings acceleration.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Jefferies_Buy_Rating_With_Rs_1300_Target_Supports_Premium_Valuation\"><\/span><strong>Jefferies Buy Rating With Rs 1,300 Target Supports Premium Valuation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Jefferies maintains a Buy rating on Sai Life Sciences with a target price of Rs 1,300, which implies further upside from the current 52-week high of Rs 1,252. The brokerage cites limited Middle East impact on business, cost pass-through capability, and strong project wins as the key differentiators. The Sai Life Sciences latest news of analyst backing at a target above the 52-week high signals that institutional investors see further re-rating potential in the CRDMO growth story.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Indias_CRDMO_Sector_Growth_and_Sai_Life_Sciences_Integrated_Platform\"><\/span><strong>India&#8217;s CRDMO Sector Growth and Sai Life Sciences&#8217; Integrated Platform<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s CRDMO sector is one of the fastest-growing segments of the pharmaceutical services industry globally, as large pharma companies de-risk supply chains away from China-only dependencies. Sai Life Sciences&#8217; integrated discovery-to-commercial model (spanning medicinal chemistry, biology, process development, and manufacturing) allows it to capture value across the entire drug development chain. This end-to-end capability is rare among Indian CRDMO companies and commands a premium from global pharma partners.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Use the Univest Screener to Track Live Price and Key Fundamentals<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Market_Analysts_Are_Saying_About_Sai_Life_Sciences_Latest_News\"><\/span><strong>What Market Analysts Are Saying About Sai Life Sciences Latest News<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Jefferies maintains a Buy with a target of Rs 1,300 on Sai Life Sciences, representing meaningful upside from the current 52-week high of Rs 1,252. The company&#8217;s FY26 revenue growth of 31% and near-doubling of PAT place it among the fastest-growing listed CRDMO companies in India. The Sai Life Sciences latest news of consistent 52-week high moves reflects the structural re-rating of the CRDMO sector as India becomes a preferred pharma outsourcing destination post global supply chain disruptions.<\/p>\n<p>Ankit Jaiswal, Senior Research Analyst at Univest, notes that the Sai Life Sciences latest news near or at 52-week high is supported by genuine fundamental strength. He advises investors who missed the initial move to wait for consolidation above Rs 1,050 before considering a fresh position, rather than chasing at the peak of the move.<\/p>\n<p>Kunal Singla, Research Analyst at Univest, observes that as long as the Sai Life Sciences latest news stock holds above Rs 1,050 on weekly closes, the bullish trend structure remains intact and the Rs 1,300 to 1,500 zone is achievable over the coming weeks. He notes that Sai Life Sciences latest news near all-time-high levels can sustain if fundamental momentum continues.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sai_Life_Sciences_Latest_News_Next_Price_Targets_and_Key_Levels\"><\/span><strong>Sai Life Sciences Latest News: Next Price Targets and Key Levels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Following the Sai Life Sciences latest news rally to near or at 52-week highs, the key price levels are:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px; margin: 12px 0;\">\n<tbody>\n<tr style=\"background: #1F3864; color: #ffffff;\">\n<th style=\"padding: 8px; text-align: left;\">Level<\/th>\n<th style=\"padding: 8px; text-align: left;\">Price (Rs)<\/th>\n<th style=\"padding: 8px; text-align: left;\">Significance<\/th>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Current Price \/ 52-Week High<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">1,252 \/ 1,252<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Current level and breakout reference<\/td>\n<\/tr>\n<tr style=\"background: #F5F7FA;\">\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Near-Term Target<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">1,300 to 1,500<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Based on analyst views and technical momentum<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Key Support<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">1,050<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Weekly close support; hold here = trend intact<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>These are technical reference levels and not guaranteed targets. Please consult a SEBI-registered financial advisor before making any investment decision in Sai Life Sciences.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Monitor\"><\/span><strong>Key Risks to Monitor<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"IGST_Demand_of_Rs_1629_Crore_Pending_Legal_and_Financial_Risk\"><\/span><strong>IGST Demand of Rs 162.9 Crore Pending: Legal and Financial Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sai Life Sciences faces an IGST demand of Rs 162.9 crore with additional interest of Rs 133.2 crore and penalty of Rs 32.6 crore. The company plans to appeal and expects no material financial impact, but the total contingent liability of Rs 328.7 crore is significant relative to FY26 PAT of Rs 341.5 crore. Adverse outcome would materially impact reported earnings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"High_PE_of_7431x_Requires_Sustained_PAT_Growth\"><\/span><strong>High P\/E of 74.31x Requires Sustained PAT Growth<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At 74.31x P\/E on FY26 earnings, Sai Life Sciences is priced for sustained 25 to 35% PAT growth over multiple years. Any slowdown in FY27 revenue growth (due to project delays, client order reductions, or Middle East geopolitical impact on clients) would create a valuation de-rating from the current 52-week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"China1_CRDMO_Competition_from_Divis_Suven_and_Global_CDMOs\"><\/span><strong>China+1 CRDMO Competition from Divi&#8217;s, Suven, and Global CDMOs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The India CRDMO opportunity is attracting significant competition from Divi&#8217;s Laboratories, Suven Pharmaceuticals, Ami Organics, and global CDMOs like Samsung Biologics and Lonza. Winning and retaining large molecule and innovative drug development programmes requires sustained R&amp;D investment, regulatory track record, and client confidence that takes years to build.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Sai Life Sciences latest news story of a near or at 52-week high is backed by strong fundamental performance and key business catalysts. Ankit Jaiswal of Univest notes the fundamental story is compelling and advises disciplined entry strategy. Kunal Singla observes the target of Rs 1,300 to 1,500 is achievable as long as the stock holds Rs 1,050 on weekly closes. Investors should track the <a href=\"https:\/\/univest.in\/indices\/nifty-pharma\/nifty-pharma-share-price-today\">Nifty Pharma<\/a> index for sector-level signals alongside company-specific developments. Please consult a SEBI-registered investment advisor before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Sai Life Sciences live price and receive expert daily stock research.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Sai_Life_Sciences_Latest_News\"><\/span><strong>Frequently Asked Questions on Sai Life Sciences Latest News<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Sai_Life_Sciences_latest_news_today\"><\/span><strong>What is Sai Life Sciences latest news today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sai Life Sciences latest news is that the stock hit a 52-week high of Rs 1,252, driven by exceptional FY26 results (revenue +31% to Rs 2,153 crore, PAT nearly doubled to Rs 341.5 crore), Jefferies Buy rating with target Rs 1,300, and India&#8217;s CRDMO sector structural growth as global pharma companies diversify supply chains away from China. The stock has surged 68% from its 52-week low of Rs 744.10.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Sai_Life_Sciences_at_52-week_high\"><\/span><strong>Why is Sai Life Sciences at 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sai Life Sciences is at a 52-week high because FY26 revenue grew 31% to Rs 2,153 crore and PAT nearly doubled to Rs 341.5 crore from Rs 173.5 crore in FY25. Jefferies maintains Buy with a target of Rs 1,300, citing cost pass-through capability and strong project wins. The company benefits from India&#8217;s CRDMO growth as global pharma reduces China dependence.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Sai_Life_Sciences_business_model\"><\/span><strong>What is Sai Life Sciences&#8217; business model?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sai Life Sciences is a CRDMO (Contract Research, Development, and Manufacturing Organization) providing integrated services from drug discovery (medicinal chemistry, biology, DMPK) through development (process development, analytical, CMC) to commercial manufacturing. This integrated end-to-end model allows the company to retain clients across the full drug development lifecycle, creating long-term sticky relationships with global pharmaceutical innovators.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Jefferies_target_for_Sai_Life_Sciences\"><\/span><strong>What is the Jefferies target for Sai Life Sciences?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Jefferies maintains a Buy rating on Sai Life Sciences with a target price of Rs 1,300, representing approximately 3.8% upside from the current 52-week high of Rs 1,252. The brokerage cites limited Middle East exposure impact, cost pass-through capability, and strong project wins as the key investment thesis. FY26 PAT growth of 97% to Rs 341.5 crore validates the high-growth CRDMO thesis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Sai_Life_Sciencess_market_cap_and_valuation_at_current_levels\"><\/span><strong>What is Sai Life Sciences&#8217;s market cap and valuation at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At the current price of Rs 1,252, Sai Life Sciences has a market capitalisation of approximately Rs ~26,500 crore and trades at a P\/E ratio of 74.31x. The 52-week high is Rs 1,252 and the 52-week low is Rs 744.10, representing a ~68% return from the low. Verify all data at nseindia.com before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Sai_Life_Sciences_a_buy_at_current_levels\"><\/span><strong>Is Sai Life Sciences a buy at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Whether Sai Life Sciences is a buy at current levels depends on your investment horizon and risk tolerance. The fundamental drivers behind today&#8217;s move are real and medium-term positive. However, buying at or near 52-week highs carries short-term correction risk. Ankit Jaiswal of Univest recommends waiting for consolidation above Rs 1,050 before initiating fresh positions. This is not investment advice. Consult a SEBI-registered financial advisor.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Latest Sai Life Sciences latest news: Sai Life Sciences Scales 52-Week High of Rs 1,252. Analyst views, next targets and key risks.<\/p>\n","protected":false},"author":35,"featured_media":142774,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-134221","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1783428699:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["81"],"rank_math_title":["Sai Life Sciences Latest News: Scales 52-Week High of Rs 1,252"],"rank_math_description":["Sai Life Sciences latest news: Sai Life Sciences (NSE: SAILIFE) hit a 52-week high of Rs 1,252. MCap Rs ~26,500 Cr, P\/E 74.31x. Key reasons and analyst views."],"rank_math_focus_keyword":["Sai Life Sciences latest news"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["142774"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["24171"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Sai-Life-Sciences-Latest-News-Sai-Life-Sciences-Scales-52-Week-High-of-Rs-1252-Backed-by-Strong-Fundamentals.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/134221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=134221"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/134221\/revisions"}],"predecessor-version":[{"id":142775,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/134221\/revisions\/142775"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/142774"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=134221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=134221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=134221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}